An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo-Reference-Cited by-同舟云学术

An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo

Published:2015-02 Issue:1 Volume:357 Page:364-373
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kiesgen Stefan,Arndt Michaela A.E.,Körber Christoph,Arnold Ulrich,Weber Tobias,Halama Niels,Keller Armin,Bötticher Benedikt,Schlegelmilch Anne,Liebers Nora,Cremer Martin,Herold-Mende Christel,Dyckhoff Gerhard^ORCID,Federspil Philippe A.,Jensen Alexandra D.,Jäger Dirk,Kontermann Roland E.,Mier Walter,Krauss Jürgen

Funder

Deutsche Krebshilfe

Helmholtz Alliance for Immunotherapy

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Epidermal growth factor receptor (EGFR) signaling in cancer;Normanno;Gene,2006

2. EGFR and cancer prognosis;Nicholson;Eur. J. Cancer,2001

3. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer;Bonanno;Curr. Drug Targets,2011

4. Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab;Brand;Cancer Biol. Ther,2011

5. EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance;Lo;Curr. Mol. Pharmacol,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections;International Journal of Molecular Sciences;2022-06-12

2. Potent anti-tumor activity of CD45RA-targeting Hm3A4-Ranpirnase against myeloid lineage leukemias;Bioengineered;2022-03-24

3. Specific Targeting of Recombinant Human Pancreatic Ribonuclease 1 using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells;IRAN J MED SCI;2021

4. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs;Frontiers in Immunology;2019-11-26

5. Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells;Biomedicines;2018-03-05